What does “adalimumab” cost, and why is it different from country to country?
“Adalimumab” is the generic name for medicines sold under multiple brand names (most famously Humira). The out-of-pocket price (and even the billed “list price”) depends heavily on your country, insurer or national health program, and the specific product/strength/formulation.
If you meant “adalimumab BWWD price” as a specific brand/program, the exact meaning depends on what “BWWD” stands for in your location or payer system. With only “adalimumab bwwd price,” I can’t reliably identify the exact pricing source or product.
How to find the adalimumab price you can actually pay (fast)
To get a usable number, you usually need these details:
- Country (and currency)
- Brand or biosimilar name (for example, Humira vs a specific adalimumab biosimilar)
- Dose/pack size (because prices are often quoted per pen/syringe/pack)
- Whether you’re using insurance, Medicare/Medicaid, or a cash-pay option
- Pharmacy vs hospital outpatient billing
Is adalimumab getting cheaper because of biosimilars?
In many markets, adalimumab biosimilars have reduced prices versus the original originator product, but the size of the savings depends on local reimbursement rules, tendering, and whether your insurer prefers a specific biosimilar.
If you tell me your country and the brand/biosimilar name you’re referring to, I can point you to the right kind of pricing figure (cash price vs reimbursed price vs list price) rather than guessing.
Quick clarifying question
What does “BWWD” mean for you (a brand name, pharmacy name, country program, or insurance plan), and what country are you asking about? Once I have that, I can give the most relevant adalimumab price you’re likely to see.